14-day Premium Trial Subscription Try For FreeTry Free

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 0.000 67 days ( -5.44 % )
Last Price $0.0960 0 %
High/ Low $0.0960 - $0.0960 0%
Chg 7 Days N/A $0.0960 $0.0960
Chg 30 Days N/A $0.0960 $0.0960
Chg 12 mos -29.36 % $0.136 $0.0960
Trend - 3 mos N/A Width: 0 %
Trend - 12 mos -4.33 % Width: 196.86 %
Pred. range - 3 mos N/A - N/A -100.00 % - -100.00 %
Pred. range - 12 mos $0.0448 - $0.133 -53.36 % - 38.47 %
Short MA avg 3 mos Sell Nov 30, -1 - N/A days
Long MA avg 3 mos Sell Nov 30, -1 - N/A days
Short/Long MA avg 3 mos Sell Nov 30, -1 - N/A days
Short MA avg 12 mos Buy Dec 13, 2023 - 73 days
Long MA avg 12 mos Buy Dec 18, 2023 - 70 days
Short/Long MA avg 12 mos Buy Dec 21, 2023 - 67 days
Pivot Short Sell Mar 27, 2024 - 2 days
Bollinger Sell Nov 30, -1 - N/A days
MACD N/A No Dates Stored For This Signal
Click to get the best stock tips daily for free!

About Aptinyx Inc

Aptinyx Aptinyx Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel, proprietary, and synthetic small molecules for the treatment of brain and nervous system disorders. The company is developing NYX-2925, which is in Phase II clinical development for the treatment of painful diabetic peripheral neuropathy, as well as in Phase II/b clinical trial for treating fibromyalgia. It is also deve... APTX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT